Skip to main content


Swipe om te navigeren naar een ander artikel

01-08-2020 | Review Article | bijlage 1/2020 Open Access

Netherlands Heart Journal 1/2020

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care

Netherlands Heart Journal > bijlage 1/2020
L. M. G. Meems, D. J. van Veldhuisen, R. A. de Boer


Heart failure (HF) remains a major global problem. In the Netherlands, 1.5–2.0% of the total population is diagnosed with HF. Over 30,000 HF patients are admitted annually in the Netherlands, and this number is expected to further increase given the ageing population and the chronic nature of HF. Despite ongoing efforts to reduce the burden of HF, morbidity and mortality rates of this disease remain high. However, several new treatment modalities have become available or are expected to become available in the coming years. This review will provide an overview of HF research conducted in the Netherlands (often in an international setting) that may have clinical consequences for diagnosis, treatment and prevention of HF, and will also evaluate outcomes of larger clinical trials that have been conducted in the Netherlands.

Onze productaanbevelingen

Netherlands Heart Journal

Het Netherlands Heart Journal wordt uitgegeven in samenwerking met de Nederlandse Vereniging voor Cardiologie en de Nederlandse Hartstichting. Het tijdschrift is Engelstalig en wordt gratis beschikbaa ...

Over dit artikel

Andere artikelen bijlage 1/2020

Netherlands Heart Journal 1/2020 Naar de uitgave